Dementia with Lewy bodies (DLB) is one of the major neurodegenerative diseases affecting older adults, and it is often considered the second most common form of degenerative dementia after Alzheimer disease. A newly published systematic review and meta-analysis in JAMA Neurology provides one of the most comprehensive population-based estimates to date on how often DLB occurs worldwide and how its frequency varies by age and sex.
This article breaks down the key findings in simple terms, focusing on incidence (new cases over time), prevalence (total existing cases), and what these numbers mean for patients, caregivers, healthcare systems, and future research.
Dementia with Lewy bodies is a progressive brain disorder caused by abnormal deposits of a protein called alpha-synuclein. These deposits form Lewy bodies, which interfere with normal brain function.
Common symptoms include:
Because these symptoms overlap with Alzheimer disease and Parkinson disease dementia, DLB is frequently underdiagnosed or misdiagnosed.
Before this analysis, global estimates of DLB were inconsistent and often based on small or region-specific studies. That made it difficult for healthcare systems to understand its true burden.
This systematic review and meta-analysis combined data from 16 population-based studies across multiple countries to produce more reliable global estimates of DLB incidence and prevalence.
The study found that:
This means that for every 100,000 people followed for one year, fewer than 5 new cases of DLB are diagnosed on average.
Age was the strongest factor influencing risk.
This confirms that DLB is primarily a late-life condition, although it can occasionally appear earlier.
The study also found a modest difference by sex:
While the difference is not extreme, it suggests slightly higher risk in males, though the reasons remain unclear.
Prevalence refers to how many people are living with the disease at a given time.
A key limitation in the research is that very few studies reported full population prevalence data. Only one study provided an all-age estimate, which was:
This highlights a major gap in global surveillance of DLB.
The study emphasizes several challenges that make accurate estimation difficult:
DLB is often mistaken for Alzheimer disease or Parkinson disease dementia.
Cognitive decline, hallucinations, and motor symptoms appear in multiple neurodegenerative disorders.
Different studies used different systems, including:
Many cases may go unrecognized, especially in patients with multiple health conditions.
The included studies came mainly from:
However, most research came from high-income countries. This creates a gap in understanding DLB in low- and middle-income regions, where diagnostic resources may be more limited.
The researchers note that this limits how globally representative the estimates are.
The sharp rise in cases after age 65 reflects general patterns seen in neurodegenerative disease. As the brain ages, it becomes more vulnerable to protein aggregation, vascular changes, and mixed pathologies.
DLB also commonly overlaps with Alzheimer disease pathology, meaning many older patients may have mixed forms of dementia.
The study notes that DLB is more common than several other rare neurodegenerative disorders, including:
This makes DLB relatively uncommon in absolute terms, but still an important public health concern due to its severity and care needs.
Even though DLB is relatively rare compared with Alzheimer disease, it carries a heavy burden:
These factors make accurate diagnosis and planning essential for healthcare systems.
The authors highlight several limitations:
Because of this, the reported numbers likely represent a minimum estimate rather than the true global burden.
This study provides the most reliable population-based estimates of DLB to date, but it also highlights the need for:
As diagnostic tools improve, reported incidence and prevalence may increase, not because the disease is becoming more common, but because detection is improving.
Dementia with Lewy bodies is a rare but important neurodegenerative disease that primarily affects older adults. This new meta-analysis shows that:
Understanding its true burden is essential for improving diagnosis, care planning, and support for patients and caregivers.
Urso D, Giannoni-Luza S, Giannelli T, et al. Incidence and Prevalence of Dementia With Lewy Bodies: A Systematic Review and Meta-Analysis. JAMA Neurology. 2026.
This article is a simplified, summary of peer-reviewed medical research. It is for informational and educational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for medical concerns or decisions.
Most Accurate Healthcare AI designed for everything from admin workflows to clinical decision support.